Mimoun Azzouz, Professor of Translational Neuroscience, discusses and demonstrates the gene-based therapy for Motor Neurone Disease (MND) being carried out at the…
Oliver Bandmann, Professor of Movement Disorders, gives an introduction to Parkinson's Disease and provides an oversight of the SITRaN research into treating the…
Gaia Brezzo, Psychology. Get introduced to the concept of functional magnetic resonance imaging (fMRI) through mind reading tricks performed by amateur mind reader…
Alejandro Lorente Pons, Neuroscience. Motor Neurone Disease (MND) is a neurodegenerative disease that causes great physical disability in patients. The reasons why this…
Dr Christopher McDermott, Consultant Neurologist and Reader in Neurology at SITraN, gives an introduction to the research being done into understanding Motor Neurone…
Dr Esther Hobson, National Institute for Health Research Doctoral Research Fellow at SITraN, demonstrates 'TiM', a web-based pilot system for more effective…
Filmmaker Cathy Soreny (Optical Jukebox) and Digital Consultant Rebecca Bartlet (Ammba) describe the processes and thinking behind 'myNIV', an online resource…
Dr Susan Baxter, Research Fellow at the School of Health and Related Research (ScHARR), describes the technology and processes involved in Non-Invasive Ventilation, a…
The availability of touchscreen tablet devices on the market has led to an increased interest in their potential usefulness for people with dementia, particularly for…
Economic evaluation of healthcare interventions follows the guideline produced by the National Institute for Health and Care Excellence (NICE). NICE recommends a Cost…
Amyloid beta deposition in the brain is the hallmark of Alzheimers disease. Co-deposition of other amyloidogenic proteins like transthyretin, human cystatin C have been…
Why do most of us only get dementia when we grow old? One suggestion is that in the young, some proteins interact with the species known to be involved in dementia…
Hearing loss is generally underdiagnosed in the population but it is estimated to affect 1 in 6 people, and 2/3 of these will be over 65. One of the most common causes…
Society’s response to dementia must be multi-faceted and at the University of Sheffield we have an impressive track record contributing to this response. Building…
The lack of treatment available for Alzheimer’s disease and the large number of people living with the disease advocate the need to develop tools for early and…
It is believed that in many amyloid diseases, including Alzheimer’s, the primary toxic species responsible for neurodegeneration are small oligomers of the…